238 related articles for article (PubMed ID: 31878304)
1. Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly.
Thamban Chandrika N; Fosso MY; Tsodikov OV; LeVine Iii H; Garneau-Tsodikova S
Molecules; 2019 Dec; 25(1):. PubMed ID: 31878304
[TBL] [Abstract][Full Text] [Related]
2. Effects of structural modifications on the metal binding, anti-amyloid activity, and cholinesterase inhibitory activity of chalcones.
Fosso MY; LeVine H; Green KD; Tsodikov OV; Garneau-Tsodikova S
Org Biomol Chem; 2015 Sep; 13(36):9418-26. PubMed ID: 26248214
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
5. Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease.
Mezeiova E; Chalupova K; Nepovimova E; Gorecki L; Prchal L; Malinak D; Kuca K; Soukup O; Korabecny J
Curr Alzheimer Res; 2019; 16(9):772-800. PubMed ID: 30819078
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of Structural Modifications on the Competition of Chalcones for the PIB Amyloid Imaging Ligand-Binding Site in Alzheimer's Disease Brain and Synthetic Aβ Fibrils.
Fosso MY; McCarty K; Head E; Garneau-Tsodikova S; LeVine H
ACS Chem Neurosci; 2016 Feb; 7(2):171-6. PubMed ID: 26682772
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors.
Green KD; Fosso MY; Garneau-Tsodikova S
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544832
[TBL] [Abstract][Full Text] [Related]
9. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z
Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034
[TBL] [Abstract][Full Text] [Related]
10. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
11. Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation.
Markowicz-Piasecka M; Huttunen KM; Sikora J
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1309-1322. PubMed ID: 30251898
[TBL] [Abstract][Full Text] [Related]
12. A Coumarin-Donepezil Hybrid as a Blood-Brain Barrier Permeable Dual Cholinesterase Inhibitor: Isolation, Synthetic Modifications, and Biological Evaluation of Natural Coumarins.
Sharma A; Nuthakki VK; Gairola S; Singh B; Bharate SB
ChemMedChem; 2022 Sep; 17(18):e202200300. PubMed ID: 35892288
[TBL] [Abstract][Full Text] [Related]
13. [Design, synthesis and evaluation of bis-nicotine derivatives as inhibitors of cholinesterases and beta-amyloid aggregation].
Luo W; Zhao YM; Tian RG; Su YB; Hong C
Yao Xue Xue Bao; 2013 Nov; 48(11):1671-6. PubMed ID: 24475704
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of Piperazine and
Waiker DK; Verma A; Akhilesh ; A GT; Singh N; Roy A; Dilnashin H; Tiwari V; Trigun SK; Singh SP; Krishnamurthy S; Lama P; Davisson VJ; Shrivastava SK
ACS Chem Neurosci; 2023 Jun; 14(11):2217-2242. PubMed ID: 37216500
[TBL] [Abstract][Full Text] [Related]
15. Donepezil-melatonin hybrids as butyrylcholinesterase inhibitors: Improving binding affinity through varying mode of linking fragments.
Łozińska I; Świerczyńska A; Molęda Z; Hartman AM; Hirsch AKH; Czarnocki Z
Arch Pharm (Weinheim); 2018 Nov; 351(11):e1800194. PubMed ID: 30290008
[TBL] [Abstract][Full Text] [Related]
16. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors.
Kang L; Gao XH; Liu HR; Men X; Wu HN; Cui PW; Oldfield E; Yan JY
Mol Divers; 2018 Nov; 22(4):893-906. PubMed ID: 29934672
[TBL] [Abstract][Full Text] [Related]
18. Novel Donepezil-Arylsulfonamide Hybrids as Multitarget-Directed Ligands for Potential Treatment of Alzheimer's Disease.
Queda F; Calò S; Gwizdala K; Magalhães JD; Cardoso SM; Chaves S; Piemontese L; Santos MA
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809771
[TBL] [Abstract][Full Text] [Related]
19. Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's Disease.
Rampa A; Bartolini M; Pruccoli L; Naldi M; Iriepa I; Moraleda I; Belluti F; Gobbi S; Tarozzi A; Bisi A
Molecules; 2018 Jul; 23(8):. PubMed ID: 30061534
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel tris-chalcones and determination of their inhibition profiles against some metabolic enzymes.
Burmaoglu S; Yilmaz AO; Polat MF; Kaya R; Gulcin İ; Algul O
Arch Physiol Biochem; 2021 Apr; 127(2):153-161. PubMed ID: 31172840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]